Kidney failure patients undergoing hemodialysis.
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Age 30-60 years- BMI 30- 18/5 At least 6 months of hemodialysis- Ability and willingness to collaborate on the project
Exclusion criteria
Exclusion criteria: Underlying diseases including stage 3 and 4 heart failure severe liver and thyroid disease malignancy Regular use of supplements or pomegranate juice in the past 3 months Smoking, alcohol and hookah use Use of steroidal and non-steroidal anti-inflammatory drugs Severe reaction to supplements and placebo Pregnancy during the study period Hospitalization due to disease activation during the intervention
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Uremic toxin levels in dialysis patients. Timepoint: Measurement of uremic toxins (p-crsol and indoxyl sulfate) levels at the beginning and after 10 weeks, i.e. the end of the study. Method of measurement: 10 cc of venous blood after 12 hours of fasting (at the beginning and end of the study) using the ELISA kit method. | — |
Countries
Iran (Islamic Republic of)
Contacts
Iran University of Medical Sciences